CD69 and neoplasm: These experiments, however, did not determine whether the protective T cells consisted of noncirculating tumor resident cells or circulating T cells derived from nonlymphoid tissue, nor have they identified the nature of the T cells, whether they corresponded to the phenotypically defined CD69+CD103+ and/or CD69+CD49a+ canonical Trm.